Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
Department of Medicine and Surgery, Unit of Oral Medicine and Pathology, University of Insubria, Varese, Italy.
Cochrane Database Syst Rev. 2021 Feb 24;2(2):CD003811. doi: 10.1002/14651858.CD003811.pub3.
The most frequent indications for tooth extractions, generally performed by general dental practitioners, are dental caries and periodontal infections. Systemic antibiotics may be prescribed to patients undergoing extractions to prevent complications due to infection. This is an update of a review first published in 2012.
To determine the effect of systemic antibiotic prophylaxis on the prevention of infectious complications following tooth extractions.
Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health Trials Register (to 16 April 2020), the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library, 2020, Issue 3), MEDLINE Ovid (1946 to 16 April 2020), Embase Ovid (1980 to 16 April 2020), and LILACS (1982 to 16 April 2020). The US National Institutes of Health Trials Registry (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials. No restrictions were placed on the language or date of publication when searching the electronic databases.
We included randomised, double-blind, placebo-controlled trials of systemic antibiotic prophylaxis in patients undergoing tooth extraction(s) for any indication.
At least two review authors independently performed data extraction and 'Risk of bias' assessment for the included studies. We contacted trial authors for further details where these were unclear. For dichotomous outcomes, we calculated risk ratios (RR) and 95% confidence intervals (CI) using random-effects models. For continuous outcomes, we used mean differences (MD) with 95% CI using random-effects models. We examined potential sources of heterogeneity. We assessed the certainty of the body of evidence for key outcomes as high, moderate, low, or very low, using the GRADE approach.
We included 23 trials that randomised approximately 3206 participants (2583 analysed) to prophylactic antibiotics or placebo. Although general dentists perform dental extractions because of severe dental caries or periodontal infection, only one of the trials evaluated the role of antibiotic prophylaxis in groups of patients affected by those clinical conditions. We assessed 16 trials as being at high risk of bias, three at low risk, and four as unclear. Compared to placebo, antibiotics may reduce the risk of postsurgical infectious complications in patients undergoing third molar extractions by approximately 66% (RR 0.34, 95% CI 0.19 to 0.64; 1728 participants; 12 studies; low-certainty evidence), which means that 19 people (95% CI 15 to 34) need to be treated with antibiotics to prevent one infection following extraction of impacted wisdom teeth. Antibiotics may also reduce the risk of dry socket by 34% (RR 0.66, 95% CI 0.45 to 0.97; 1882 participants; 13 studies; low-certainty evidence), which means that 46 people (95% CI 29 to 62) need to take antibiotics to prevent one case of dry socket following extraction of impacted wisdom teeth. The evidence for our other outcomes is uncertain: pain, whether measured dichotomously as presence or absence (RR 0.59, 95% CI 0.31 to 1.12; 675 participants; 3 studies) or continuously using a visual analogue scale (0-to-10-centimetre scale, where 0 is no pain) (MD -0.26, 95% CI -0.59 to 0.07; 422 participants; 4 studies); fever (RR 0.66, 95% CI 0.24 to 1.79; 475 participants; 4 studies); and adverse effects, which were mild and transient (RR 1.46, 95% CI 0.81 to 2.64; 1277 participants; 8 studies) (very low-certainty evidence). We found no clear evidence that the timing of antibiotic administration (preoperative, postoperative, or both) was important. The included studies enrolled a subset of patients undergoing dental extractions, that is healthy people who had surgical extraction of third molars. Consequently, the results of this review may not be generalisable to all people undergoing tooth extractions.
AUTHORS' CONCLUSIONS: The vast majority (21 out of 23) of the trials included in this review included only healthy patients undergoing extraction of impacted third molars, often performed by oral surgeons. None of the studies evaluated tooth extraction in immunocompromised patients. We found low-certainty evidence that prophylactic antibiotics may reduce the risk of infection and dry socket following third molar extraction when compared to placebo, and very low-certainty evidence of no increase in the risk of adverse effects. On average, treating 19 healthy patients with prophylactic antibiotics may stop one person from getting an infection. It is unclear whether the evidence in this review is generalisable to patients with concomitant illnesses or patients at a higher risk of infection. Due to the increasing prevalence of bacteria that are resistant to antibiotic treatment, clinicians should evaluate if and when to prescribe prophylactic antibiotic therapy before a dental extraction for each patient on the basis of the patient's clinical conditions (healthy or affected by systemic pathology) and level of risk from infective complications. Immunocompromised patients, in particular, need an individualised approach in consultation with their treating medical specialist.
最常见的拔牙适应证通常由普通牙医执行,包括龋齿和牙周感染。为了预防感染,可能会给接受拔牙的患者开具全身抗生素。这是对 2012 年首次发表的综述的更新。
评估拔牙后预防性使用全身抗生素对预防感染性并发症的效果。
Cochrane 口腔健康组的信息专家检索了以下数据库:Cochrane 口腔健康试验注册库(截至 2020 年 4 月 16 日)、Cochrane 中央对照试验注册库(Cochrane 图书馆,2020 年,第 3 期)、MEDLINE Ovid(1946 年至 2020 年 4 月 16 日)、Embase Ovid(1980 年至 2020 年 4 月 16 日)和 LILACS(1982 年至 2020 年 4 月 16 日)。美国国立卫生研究院临床试验注册处(ClinicalTrials.gov)和世界卫生组织国际临床试验注册平台也对正在进行的试验进行了检索。在电子数据库中搜索时,对语言和发布日期没有限制。
我们纳入了接受任何适应证拔牙的患者接受全身抗生素预防的随机、双盲、安慰剂对照试验。
至少两名综述作者独立对纳入研究进行数据提取和“偏倚风险”评估。我们在不清楚的情况下联系了试验作者以获取更多细节。对于二分类结局,我们使用随机效应模型计算风险比(RR)和 95%置信区间(CI)。对于连续结局,我们使用随机效应模型计算均值差(MD)和 95%置信区间。我们检查了潜在的异质性来源。我们使用 GRADE 方法评估关键结局的证据确定性为高、中、低或极低。
我们纳入了 23 项试验,共纳入约 3206 名参与者(2583 名接受分析),分为抗生素组或安慰剂组。尽管普通牙医因严重龋齿或牙周感染而进行拔牙,但只有一项试验评估了抗生素预防在受这些临床情况影响的患者群体中的作用。我们评估了 16 项试验为高偏倚风险,3 项为低偏倚风险,4 项为不确定偏倚风险。与安慰剂相比,抗生素可能使接受第三磨牙拔除的患者术后感染性并发症的风险降低约 66%(RR 0.34,95%CI 0.19 至 0.64;1728 名参与者;12 项研究;低质量证据),这意味着每 19 名接受拔牙的患者中就有 1 人需要接受抗生素治疗以预防感染。抗生素也可能使干槽症的风险降低 34%(RR 0.66,95%CI 0.45 至 0.97;1882 名参与者;13 项研究;低质量证据),这意味着每 46 名接受拔牙的患者中就有 1 人需要接受抗生素治疗以预防干槽症。我们其他结局的证据不确定:疼痛,无论是以存在或不存在的二分法(RR 0.59,95%CI 0.31 至 1.12;675 名参与者;3 项研究)还是连续使用视觉模拟量表(0 至 10 厘米刻度,其中 0 表示无痛)(MD -0.26,95%CI -0.59 至 0.07;422 名参与者;4 项研究);发热(RR 0.66,95%CI 0.24 至 1.79;475 名参与者;4 项研究)和不良事件,这些不良事件是轻微和短暂的(RR 1.46,95%CI 0.81 至 2.64;1277 名参与者;8 项研究)(极低质量证据)。我们发现抗生素给药时间(术前、术后或两者兼而有之)是否重要的证据并不明确。纳入的研究纳入了接受拔牙的患者的一个子集,即接受手术拔除第三磨牙的健康人群。因此,本综述的结果可能不适用于所有接受拔牙的患者。
本综述纳入的 23 项试验中,绝大多数(21 项)仅纳入了接受第三磨牙拔除的健康患者,这些患者通常由口腔外科医生进行手术。没有一项研究评估免疫功能低下患者的拔牙情况。我们发现低质量证据表明,与安慰剂相比,预防性使用抗生素可能会降低第三磨牙拔除后的感染和干槽症风险,而非常低质量证据表明不会增加不良反应的风险。平均而言,每 19 名健康患者接受预防性抗生素治疗,就可以阻止 1 人发生感染。目前尚不清楚本综述中的证据是否可推广至伴有合并症的患者或感染风险较高的患者。由于对抗生素治疗有耐药性的细菌越来越多,临床医生应根据患者的临床状况(健康或受系统性疾病影响)和感染性并发症的风险水平,在为每位患者拔牙前评估是否需要以及何时需要预防性使用抗生素治疗。特别是免疫功能低下的患者,需要与他们的治疗医学专家进行个体化的咨询。